Almitas Capital’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6M | Sell |
445,386
-269,619
| -38% | -$971K | 0.4% | 37 |
|
|
2025
Q1 | $2.14M | Sell |
715,005
-36,998
| -5% | -$111K | 0.71% | 28 |
|
|
2024
Q4 | $2.52M | Sell |
752,003
-632,526
| -46% | -$2.12M | 0.55% | 30 |
|
|
2024
Q3 | $4.64M | Buy |
1,384,529
+94,342
| +7% | +$316K | 1.64% | 17 |
|
|
2024
Q2 | $4.27M | Buy |
+1,290,187
| New | +$4.27M | 1.78% | 13 |
|